Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
基本信息
- 批准号:8134853
- 负责人:
- 金额:$ 29.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:19q13.4AllelesBinding SitesChromosomes, Human, Pair 7DNADNA MethylationDiseaseEmbryonic DevelopmentFundingGametogenesisGenesGenetic TranscriptionGenomic ImprintingGliomaGlobal ChangeGrowthHereditary DiseaseHumanHuman ChromosomesHuman GeneticsKnockout MiceLightLinkMalignant neoplasm of ovaryModelingMolecularMono-SMusMutant Strains MiceMutateOogenesisPatientsPhenotypePlayPromoter RegionsRepressionRoleSchemeSiteSmall Interfering RNASomatic CellTestingYY1 Transcription Factorbasedosagehistone modificationimprintin vivoinsightmalignant breast neoplasmpublic health relevanceresearch studytransmission process
项目摘要
DESCRIPTION (provided by applicant): Project Summary Genomic imprinting is closely associated with human genetic disorders due to its functional hemizygosity. The Peg3 domain on human chromosome 19q13.4/proximal mouse chromosome 7 is also associated with several imprinting-related genetic disorders, including frequent loss of human PEG3 expression in the patients of glioma, breast and ovarian cancers. Thus, the long-term objective of this project is to understand the mechanisms controlling the imprinting of the Peg3 domain. In the previous funding cycle, we predicted that the Peg3 domain is likely controlled by one potential ICR (Imprinting Control Region), the Peg3-DMR (Differentially Methylated Region). We subsequently demonstrated that deletion of the Peg3-DMR has a global impact on the transcription of the Peg3 domain. Paternal and maternal transmission of this targeted deletion also resulted in decreased and increased growth rates of the mouse, respectively, an imprinting phenotype associated with proximal mouse chromosome 7. We also discovered that this potential ICR has a very unusual tandem array of YY1 binding sites, and that reducing the in vivo levels of YY1 protein during oogenesis resulted in target-specific DNA hypomethylation on the Peg3-DMR. Based on these observations, we hypothesize 1) that the imprinting of the Peg3 domain is controlled by the Peg3-DMR and 2) that this control requires YY1 as a main trans factor for targeting de novo DNA methylation during oogenesis. In the current proposal, we will test these hypotheses with the following three aims. Aim1 will further characterize the ICR roles played by the Peg3-DMR using the mutant mice lacking the Peg3-DMR. Aim2 will dissect the exact contributions of YY1 to the observed ICR roles of the Peg3-DMR by generating another KO allele with mutated YY1 sites. Aim3 will investigate potential mechanisms by which YY1 establishes and maintains the allele-specific DNA methylation of the Peg3-DMR. The results from these experiments will provide valuable insights regarding previously unnoticed roles for YY1 in genomic imprinting as well as human genetic disorders linked to the Peg3 domain.
PUBLIC HEALTH RELEVANCE: A small number of mammalian genes (less than 200) are not functionally equal between the two parental alleles due to an unusual dosage control mechanism, genomic imprinting. The current proposal is aiming to characterize regulatory mechanisms of genomic imprinting.
描述(由申请人提供):项目概述基因组印记由于其功能半合子性而与人类遗传疾病密切相关。人染色体19q13.4/近端小鼠7号染色体上的Peg 3结构域也与几种印迹相关的遗传疾病相关,包括神经胶质瘤、乳腺癌和卵巢癌患者中人PEG 3表达的频繁缺失。因此,本项目的长期目标是了解控制Peg 3结构域印迹的机制。在上一个资金周期中,我们预测Peg 3结构域可能由一个潜在的ICR(印记控制区),即Peg 3-DMR(差异甲基化区)控制。我们随后证明了Peg 3-DMR的缺失对Peg 3结构域的转录具有全局影响。这种靶向缺失的父系和母系传播也分别导致小鼠生长速率降低和增加,这是与近端小鼠7号染色体相关的印记表型。我们还发现,这种潜在的ICR具有非常不寻常的YY 1结合位点串联阵列,并且在卵子发生期间降低YY 1蛋白的体内水平导致Peg 3-DMR上的靶特异性DNA低甲基化。基于这些观察结果,我们假设1)Peg 3结构域的印记由Peg 3-DMR控制,2)这种控制需要YY 1作为卵子发生期间靶向从头DNA甲基化的主要反式因子。在本提案中,我们将以以下三个目标来检验这些假设。Aim 1将使用缺乏Peg 3-DMR的突变小鼠进一步表征Peg 3-DMR发挥的ICR作用。Aim 2将通过生成另一个具有突变YY 1位点的KO等位基因,分析YY 1对观察到的Peg 3-DMR ICR作用的确切贡献。Aim 3将研究YY 1建立和维持Peg 3-DMR等位基因特异性DNA甲基化的潜在机制。这些实验的结果将为YY 1在基因组印记中的先前未被注意的作用以及与Peg 3结构域相关的人类遗传疾病提供有价值的见解。
公共卫生关系:少数哺乳动物基因(少于200个)由于不寻常的剂量控制机制,基因组印记,在两个亲本等位基因之间功能不相等。目前的建议是旨在表征基因组印记的调控机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOOMYEONG KIM其他文献
JOOMYEONG KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOOMYEONG KIM', 18)}}的其他基金
Aebp2 as an epigenetic regulator for neural crest cell
Aebp2 作为神经嵴细胞的表观遗传调节因子
- 批准号:
8435711 - 财政年份:2013
- 资助金额:
$ 29.67万 - 项目类别:
Aebp2 as an epigenetic regulator for neural crest cell
Aebp2 作为神经嵴细胞的表观遗传调节因子
- 批准号:
9005865 - 财政年份:2013
- 资助金额:
$ 29.67万 - 项目类别:
Aebp2 as an epigenetic regulator for neural crest cell
Aebp2 作为神经嵴细胞的表观遗传调节因子
- 批准号:
8666770 - 财政年份:2013
- 资助金额:
$ 29.67万 - 项目类别:
Retrotransposon as a major source to epigenetic variations in the human genome
逆转录转座子是人类基因组表观遗传变异的主要来源
- 批准号:
7939210 - 财政年份:2010
- 资助金额:
$ 29.67万 - 项目类别:
Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
- 批准号:
7921248 - 财政年份:2009
- 资助金额:
$ 29.67万 - 项目类别:
Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
- 批准号:
6918898 - 财政年份:2004
- 资助金额:
$ 29.67万 - 项目类别:
Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
- 批准号:
7470552 - 财政年份:2004
- 资助金额:
$ 29.67万 - 项目类别:
Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
- 批准号:
7171904 - 财政年份:2004
- 资助金额:
$ 29.67万 - 项目类别:
Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
- 批准号:
8323567 - 财政年份:2004
- 资助金额:
$ 29.67万 - 项目类别:
Imprinting studies of a paternally expressed Usp29 gene
父系表达的 Usp29 基因的印记研究
- 批准号:
6727446 - 财政年份:2004
- 资助金额:
$ 29.67万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 29.67万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 29.67万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 29.67万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 29.67万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 29.67万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 29.67万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 29.67万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 29.67万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 29.67万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 29.67万 - 项目类别: